1. Home
  2. TIL vs MNSB Comparison

TIL vs MNSB Comparison

Compare TIL & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • MNSB
  • Stock Information
  • Founded
  • TIL 2018
  • MNSB 2003
  • Country
  • TIL United States
  • MNSB United States
  • Employees
  • TIL N/A
  • MNSB N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • MNSB Major Banks
  • Sector
  • TIL Health Care
  • MNSB Finance
  • Exchange
  • TIL Nasdaq
  • MNSB Nasdaq
  • Market Cap
  • TIL 177.1M
  • MNSB 170.1M
  • IPO Year
  • TIL 2021
  • MNSB N/A
  • Fundamental
  • Price
  • TIL $20.99
  • MNSB $19.70
  • Analyst Decision
  • TIL Strong Buy
  • MNSB
  • Analyst Count
  • TIL 5
  • MNSB 0
  • Target Price
  • TIL $100.67
  • MNSB N/A
  • AVG Volume (30 Days)
  • TIL 165.7K
  • MNSB 37.0K
  • Earning Date
  • TIL 11-12-2025
  • MNSB 10-27-2025
  • Dividend Yield
  • TIL N/A
  • MNSB 2.05%
  • EPS Growth
  • TIL N/A
  • MNSB N/A
  • EPS
  • TIL N/A
  • MNSB N/A
  • Revenue
  • TIL N/A
  • MNSB $64,604,000.00
  • Revenue This Year
  • TIL N/A
  • MNSB $23.19
  • Revenue Next Year
  • TIL N/A
  • MNSB $2.92
  • P/E Ratio
  • TIL N/A
  • MNSB N/A
  • Revenue Growth
  • TIL N/A
  • MNSB N/A
  • 52 Week Low
  • TIL $10.80
  • MNSB $15.00
  • 52 Week High
  • TIL $45.07
  • MNSB $22.98
  • Technical
  • Relative Strength Index (RSI)
  • TIL 49.49
  • MNSB 26.62
  • Support Level
  • TIL $17.37
  • MNSB $20.07
  • Resistance Level
  • TIL $21.45
  • MNSB $20.52
  • Average True Range (ATR)
  • TIL 1.48
  • MNSB 0.38
  • MACD
  • TIL 0.47
  • MNSB -0.16
  • Stochastic Oscillator
  • TIL 89.09
  • MNSB 13.06

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: